Miwa Sorachi, Takikawa Hiroshi, Takeuchi Rina, Mizunuma Ryo, Matsuoka Keita, Ogawa Haruo, Kato Hiroaki, Takasu Kiyosei
Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan.
RIKEN Harima Institute at SPring-8, Hyogo 679-5148 Japan.
ACS Med Chem Lett. 2024 Jan 19;15(2):287-293. doi: 10.1021/acsmedchemlett.3c00526. eCollection 2024 Feb 8.
Understanding the transport and inhibition mechanisms of substrates by P-glycoprotein (P-gp) is one of the important approaches in addressing multidrug resistance (MDR). In this study, we evaluated a variety of rhodamine derivatives as potential P-gp inhibitors targeting CmABCB1, a P-gp homologue, with a focus on their ATPase activity. Notably, a Q-rhodamine derivative with an ,'-dimethoxybenzyl ester moiety (Rh-DMB) demonstrated superior affinity and inhibitory activity, which was further confirmed by a drug susceptibility assay in yeast strains expressing CmABCB1. Results from a tryptophan fluorescence quenching experiment using a CmABCB1 mutant suggested that Rh-DMB effectively enters and binds to the inner chamber of CmABCB1. These findings underscore the promising potential of Rh-DMB as a tool for future studies aimed at elucidating the substrate-bound state of CmABCB1.
了解P-糖蛋白(P-gp)对底物的转运和抑制机制是解决多药耐药性(MDR)的重要途径之一。在本研究中,我们评估了多种罗丹明衍生物作为靶向P-gp同源物CmABCB1的潜在P-gp抑制剂,重点关注它们的ATP酶活性。值得注意的是,一种带有,'-二甲氧基苄酯部分的Q-罗丹明衍生物(Rh-DMB)表现出卓越的亲和力和抑制活性,在表达CmABCB1的酵母菌株中进行的药敏试验进一步证实了这一点。使用CmABCB1突变体进行的色氨酸荧光猝灭实验结果表明,Rh-DMB能有效进入并结合到CmABCB1的内腔。这些发现突出了Rh-DMB作为未来旨在阐明CmABCB1底物结合状态研究工具的广阔潜力。